Anne Vallerga was previously a Manager of the Institutional Review Board at Stanford University Medical School. Anne is an experienced research, clinical development and business manager and facilitated work with investigators, R&D grants, contracts and contractors, scientists and their pre-clinical and clinical research protocols.

Previously Anne Vallerga was co-leader of a team developing anti-cancer drug candidates, with two oncology drugs now in clinical testing. Prior to this, she managed a cancer drug development program at SRI International’s Pharmaceutical Drug Development Department and in the Department of Pharmaceutical Chemistry, University of California, San Francisco.

Anne has been a manager, administrator and Principal Investigator and interfaced with NCI for several years. She has also been an administrative liaison with the National Institutes of Health, the University of California Cancer Research Program and has collaborated in national and international cancer research.

Anne was trained as MA and PhD in molecular endocrinology and was employed as a tumor biologist at UC-Berkeley and UC-San Francisco.